TCM preparation for treating pulmonary heart disease

Abstract

The present invention discloses a TCM (traditional Chinese medicine) preparation for treating pulmonary heart disease, which is prepared from the following materials by weight part: 30 to 60 parts of Japanese stephania root, 25 to 50 parts of patience dock root, 20 to 40 parts of tuckahoe, 15 to 30 parts of bighead atractylodes rhizome, 10 to 25 parts of semen perillae acutae, 12 to 30 parts of common hongfennel root, 20 to 40 parts of snakegourd fruit, 15 to 35 parts of root bark of white mulberry, 12 to 30 parts of radish seed, 10 to 25 parts of Magnolia officinalis and 10 to 25 parts of common coltsfoot flower. The TCM preparation of the invention can achieve the fundamental effects of benefiting the vital energy, invigorating the circulation of blood, eliminating the blood stasis and relieving the swelling, wherein the Japanese stephania root as a monarch drug can clear away the heat and detoxify; the patience dock root as an adjuvant drug can break the stagnancy, diminish the inflammation, eliminate the dampness and detoxify; the tuckahoe can strengthen the spleen and stomach; the bighead atractylodes rhizome can regulate the middle warmer and eliminate the phlegm; the semen perillaeacutae can promote the sweating, disperse the cold, promote the circulation and alleviate the middle energizer; the common hongfennel root can open the inhibited lung-energy, clear the heat, reduce the phlegm and relieve the cough; the snakegourd fruit can nourish the lung and relieve the cough; the root bark of white mulberry can purge the lung of pathogenic fire and promote the dieresis; the radish seed can help the digestion and alleviate the asthma; the Mongolian officinalis can tonify the spleen and eliminate the dampness; and the common coltsfoot flower can nourish the lung, reinforce the insufficiency, stop dryness and eliminate phlegm. The TCM (traditional Chinese medicine) preparation for treating pulmonary heart disease of the present invention achieves the exact effects of preventing and treating the pulmonary heart disease by putting the materials into combined use.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating cor pulmonale. Background technique [0002] Pulmonary heart disease, referred to as cor pulmonale for short, is a disease of the pulmonary artery secondary to various thoracic, lung and bronchial lesions, and finally leads to heart disease characterized by hypertrophy of the right side. [0003] Most pulmonary heart diseases develop from chronic bronchitis and obstructive emphysema, and a small part are related to bronchial asthma, tuberculosis and bronchiectasis. [0004] Cor pulmonale exists all the year round, more than in winter and spring, complicated by respiratory tract infection, leading to respiratory failure and heart failure, with a high mortality rate. [0005] This disease belongs to the category of "asthma", "phlegm syndrome", edema and "drinking syndrome" in traditional Chinese medicine. At pres...

AI Technical Summary

Problems solved by technology

At present, there is no specific drug for the treatment of cor pulmonale. Penicillin is the first choice of western medicine, 2-4 million yuan per day, intravenous drip for many times, and streptomycin is added, 0.5g each time, twice a day, intramuscular injection, allergies Patients with erythromycin 1.5g, plus mycin 1.0-2.0 intravenous drip once a day, according to the disease can choose gentamicin, kanamycin, ampicillin, carbenicillin, etc., but these drugs can only relieve symptoms, not effective in curing cor pulmonale